Table 1.
Demographics in patients with spontaneous intracerebral hemorrhage and controls.
| ICH (n = 21) | Control (n = 10) | p-value | |
|---|---|---|---|
| Male, % | 16 (76.2%) | 3 (30.0%) | 0.021 |
| Age, y | 62.5 ± 11.3 | 66.1 ± 6.0 | 0.354 |
| Hypertension | 21 (100%) | 5 (50.0%) | 0.001 |
| *Mean arterial pressure, mmHg | 100 ± 16 | 96 ± 12 | 0.512 |
| Mini-mental status examination | 25.8 ± 4.1 | 27.8 ± 2.6 | 0.237 |
| Montreal cognitive assessment | 22.7 ± 5.4 | 27.8 ± 2.7 | 0.022 |
| Diabetes, % | 4 (19.0%) | 2 (20.0%) | 1.000 |
| Dyslipidemia, % | 9 (42.9%) | 6 (60.0%) | 0.458 |
| eGFR, mL/min/1.73 m2 | 72.7 ± 17.1 | 85.2 ± 14.6 | 0.059 |
| Presence of lobar CMB | 13 (61.9%) | 2 (20.0%) | 0.054 |
| Presence of deep CMB | 16 (76.2%) | 0 (0%) | <0.001 |
| WMH volume, mL | 7.0 ± 5.6 | 2.6 ± 2.9 | 0.007 |
| Enlarged perivascular space (≥20) | |||
| Centrum semiovale | 5 (23.8%) | 4 (40.0%) | 0.417 |
| Basal ganglia | 6 (28.6%) | 1 (10.0%) | 0.379 |
| Presence of lacune | 10 (47.6%) | 2 (20.0%) | 0.240 |
Values are mean (±standard deviation) or number (percentage).
*
Blood pressure was measured before CVR study.
CMB, cerebral microbleed; eGFR, estimated glomerular filtration rate; WMH, white matter hyperintensity.